Ruby Health

Value-based Care at Home

Health Tech & Life Sciences
Stealth Mode

Company Overview

Snapshot

Founded in July 2024 by Nir Katz and Dima Broslavsky, Ruby Health is an early-stage company with 1–10 employees. The company has secured funding across one round from 2 investors. In September 2024, Ruby Health raised a Seed round.

Business overview

Ruby Health operates in the Health Tech & Life Sciences sector, focusing on value-based care delivered at home. The company develops an application that utilizes artificial intelligence to assess hemoglobin levels in the blood, serving the Digital Healthcare market with a specific focus on Patient Remote Monitoring. Its target customers include patients and providers within the broader Healthcare & Life Sciences industry, as well as general consumers.

Strategic signal

In May 2025, Ruby Health's AI-powered application, which assesses hemoglobin levels, was highlighted in a new study published in the prestigious journal PNAS. The study indicated that the application's accuracy is comparable to traditional blood tests, demonstrating significant scientific validation for its core technology. This signals strong potential for the company's product in the digital healthcare market and could accelerate its adoption for remote patient monitoring.

Company Intelligence Q&A

When was Ruby Health founded?
Ruby Health was founded in July 2024.
Who are the founders of Ruby Health?
Ruby Health was founded by Nir Katz and Dima Broslavsky.
What is Ruby Health's primary focus?
Ruby Health focuses on providing value-based care at home, leveraging AI for patient remote monitoring in the digital healthcare sector.
Which investors participated in Ruby Health's Seed funding round?
In September 2024, Ruby Health secured Seed funding from investors including LionBird and AlleyCorp.
What significant scientific validation has Ruby Health received for its technology?
In May 2025, a new study published in PNAS demonstrated that Ruby Health's AI-powered application, which assesses hemoglobin levels, has an accuracy comparable to traditional blood tests.